Search for: "Tom Lamb"
Results 101 - 120
of 1,042
Sorted by Relevance
|
Sort by Date
18 Feb 2010, 12:52 pm
Reports About Sudden Breaking Of Thigh Bone In Patients Using Fosamax For Five Years Or More (Posted by Tom Lamb at DrugInjuryWatch.com) The side effects of Fosamax include osteonecrosis of the jaw (ONJ), esophageal irritation, and musculoskeletal pain. [read post]
21 Aug 2007, 8:26 am
This Second Edition Has Detailed, Useful Information For Doctors And Pharmacists (Posted by Tom Lamb at DrugInjuryWatch.com) The August 9, 2007 edition of The New England Journal of Medicine (NEJM) has an insightful book review by John P. [read post]
16 Feb 2007, 7:40 am
Plaintiff Alleged Wyeth Used False And Misleading Advertising For Prempro And Premarin, Thereby Hiding Risks (Posted by Tom Lamb at DrugInjuryWatch.com) On February 15, 2007 a federal court jury in Arkansas found the drug company Wyeth not liable for the breast cancer which 72-year old Helene Rush alleged was caused by her use of Prempro and Premarin. [read post]
13 Aug 2009, 2:43 pm
Combination Of Ethinylestradiol And Drospirenone Increases Serum Copper, A Situation That Could Be Associated With Increased Cardiovascular Risk (Posted by Tom Lamb at DrugInjuryWatch.com) In the August 1, 2009 edition of the medical journal Contraception there was an article which offers one possible explanation about why Yasmin and YAZ might cause an increased risk of developing serious side effects involving blood clots, such as pulmonary embolism (PE), deep vein thrombosis… [read post]
19 Oct 2007, 6:35 am
This Medtronic Defibrillator Lead Line Was Particularly Popular In Younger Patients Due To Its Smaller Size (Posted by Tom Lamb at DrugInjuryWatch.com) In an October 19, 2007 article, "Heart Wires May Pose More Risk for the Young", Wall Street Journal (WSJ) reporters Anna Wilde Mathews and Thomas M. [read post]
15 May 2009, 10:10 am
Some Ways That Free Drug Samples Can Harm Patients (Posted by Tom Lamb at DrugInjuryWatch.com) PLoS Medicine-- which is a peer-reviewed open-access journal published by the Public Library of Science -- published an essay by Susan Chimonas and Jerome P. [read post]
28 Oct 2011, 6:16 pm
(Posted by Tom Lamb at DrugInjuryWatch.com) On October 27, 2011 the FDA released its new drug-safety study report, "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints", which included the NuvaRing (etonogestrel / estradiol vaginal ring) -- referred to as "ETON" in this 2011 FDA study report. [read post]
31 Aug 2009, 1:45 pm
Medical Journal Letter To Editor Stated That Exact Mechanism Of Hepatotoxicity In Subject Patient Was Unknown (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported, on August 24, 2009 the FDA issued its "Early Communication" notification about an ongoing safety review of the obesity drugs Xenical (orlistat 120 mg) and Alli (orlistat 60 mg). [read post]
16 May 2007, 10:34 am
Plaintiff Simon Developed Breast Cancer After Using HRT Drugs Prempro, Premarin, And Provera (Posted by Tom Lamb at DrugInjuryWatch.com) On May 15, 2007 a Pennsylvania state court jury handed down a mixed verdict in the latest hormone replacement therapy (HRT) products liability case to go to trial, Simon v. [read post]
10 Aug 2021, 1:08 pm
(Case review is done by attorney Tom Lamb) [read post]
22 Jun 2012, 2:30 pm
New 2012 Medical Journal Article By North Carolina Orthopedic Surgeon Presents Series Of Femoral Stress Fractures In Patients Using Fosamax Or Other Bisphosphonates (Posted by Tom Lamb at DrugInjuryWatch.com) William G. [read post]
6 Jul 2007, 9:20 am
Avandia Seems Associated With Increased Rate Of Heart Failure; Less Clear Whether Glaxo's Diabetes Drug Causes Heart Attacks, Other Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) In the July 5, 2007 edition of The New England Journal of Medicine (NEJM) there are several editorials of interest to those doctors and patients who are concerned about the heart safety of GlaxoSmithKline's diabetes drug Avandia (rosiglitazone). [read post]
12 Jun 2012, 2:39 pm
Other DRSP Birth Control Pills Which Are Implicated By This New Finding Include Beyaz, Safyral, Ocella, Gianvi, Zarah, Loryna, Syeda, And Vestura (Posted by Tom Lamb at DrugInjuryWatch.com) In the February 1, 2012 edition of Current Drug Safetythere is an article, "Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety study", which just came to our attention in June 2012. [read post]
26 Sep 2008, 7:23 pm
Goodwin Will Preside Over "Double-Dose" Digitek Pill Cases Pursuant To MDL Litigation Order (Posted by Tom Lamb at DrugInjuryWatch.com) On August 13, 2008 the Judicial Panel on Multidistrict Litigation (JPMDL) issued an order creating the Digitek products liability multidistrict litigation, In Re: Digitek Products Liability Litigation, MDL No. 1968, JPMDL. [read post]
13 Mar 2009, 12:23 pm
March 2009 Drug Safety Update Article And BMJ Case Reports Item Bring Attention To Fosamax-Related Atypical Stress Fractures Or Insufficiency Fractures Of Femur (Posted by Tom Lamb at DrugInjuryWatch.com) There is an article in the March 2009 edition of the Drug Safety Update (UK) newsletter that gives us the latest run-down about femur, or thigh bone, fractures in patients using Fosamax (alendronic acid). [read post]
8 May 2008, 8:58 am
Women Have Developed Serious Side Effects Like Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) After Using This Birth Control Patch (Posted by Tom Lamb at DrugInjuryWatch.com) On May 8, 2008 Public Citizen's Health Research Group (HRG) sent its "Petition to the FDA to Ban Ortho-Evra" to Commissioner Andrew von Eschenbach. [read post]
13 Jan 2009, 2:25 pm
Discusses 16 Cases Of Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Erythema Multiforme (EM) Reported Over Two-and-a-half Years (Posted by Tom Lamb at DrugInjuryWatch.com) In an October 1, 2008 article, "FDA Alerts Doctors That Revlimid Can Cause Serious Skin Reactions In Patients", we reported that Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Erythema Multiforme (EM) have been associated with the use of Revlimid… [read post]
3 Apr 2009, 11:45 am
In April 2, 2009 Letter They State There Is "systemic corruption and wrongdoing that permeates all levels of FDA" Which Needs To End(Posted by Tom Lamb at DrugInjuryWatch.com) ABC News has posted on their website a slightly redacted copy of an April 2, 2009 letter by nine FDA staffers -- apparently in the FDA's Office of Device Evaluation -- to President Barack Obama. [read post]
11 Jan 2008, 7:32 am
Blumsohn Shines His Bright Light On This Troubling Situation And Provides A Lengthy List Of Recent Blog Posts About Zetia And Vytorin (Posted by Tom Lamb at DrugInjuryWatch.com) Over at the Scientific Misconduct Blog, Dr. [read post]
Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills
17 Feb 2012, 12:52 pm
Same General Warning About All COCs Was Added To YAZ In March 2011; And Why The One Year Delay, We Wonder (Posted by Tom Lamb at DrugInjuryWatch.com) The February 14, 2012 email captioned "What's New on the FDA Drugs Site" let us know that there was a new version of the Package Insert for Yasmin, Safyral, and Beyaz which consisted of four new sentences being added to the WARNINGS AND PRECAUTIONS section: 5.1 Thromboembolic Disorders and Other Vascular Problems… [read post]
